{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:10:34Z","timestamp":1789168234335,"version":"build-2803163510"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"DOI":"10.1309\/ajcpbv9elxc0ecvl","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T15:19:20Z","timestamp":1415719160000},"page":"837-844","source":"Crossref","is-referenced-by-count":71,"title":["Differential Expression of CD200 in B-Cell Neoplasms by Flow Cytometry Can Assist in Diagnosis, Subclassification, and Bone Marrow Staging"],"prefix":"10.1093","volume":"142","author":[{"given":"Pramoda","family":"Challagundla","sequence":"first","affiliation":[{"name":"Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Kanagal-Shamanna","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Jorgensen","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"key\n\t\t\t\t20180602034122_b1-1420837","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1309\/XV4AG7EMWQU7ER67","article-title":"CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases","volume":"120","author":"Schlette","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602034122_b2-1420837","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3324\/haematol.2009.011049","article-title":"CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases","volume":"95","author":"Baseggio","year":"2010","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20180602034122_b3-1420837","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00404426","article-title":"Characterization of the human homolog of the rat MRC OX-2 membrane glycoprotein","volume":"25","author":"McCaughan","year":"1987","journal-title":"Immunogenetics"},{"key":"key\n\t\t\t\t20180602034122_b4-1420837","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00364281","article-title":"The gene for MRC OX-2 membrane glycoprotein is localized on human chromosome 3","volume":"25","author":"McCaughan","year":"1987","journal-title":"Immunogenetics"},{"key":"key\n\t\t\t\t20180602034122_b5-1420837","first-page":"149","article-title":"Neuronal\/lymphoid membrane glycoprotein MRC OX-2 is a member of the immunoglobulin superfamily with a light-chain-like structure","volume":"51","author":"Barclay","year":"1986","journal-title":"Biochem Soc Symp"},{"key":"key\n\t\t\t\t20180602034122_b6-1420837","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2567.2001.01163.x","article-title":"The unusual distribution of the neuronal\/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans","volume":"102","author":"Wright","year":"2001","journal-title":"Immunology"},{"key":"key\n\t\t\t\t20180602034122_b7-1420837","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1038\/onc.2011.477","article-title":"CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor","volume":"31","author":"Rygiel","year":"2012","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180602034122_b8-1420837","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.4049\/jimmunol.178.9.5595","article-title":"CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy","volume":"178","author":"Kretz-Rommel","year":"2007","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180602034122_b9-1420837","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14712598.8.1.5","article-title":"Rationale for anti-CD200 immunotherapy in B-CLL and other hematologic malignancies: new concepts in blocking immune suppression","volume":"8","author":"Kretz-Rommel","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"key\n\t\t\t\t20180602034122_b10-1420837","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1189\/jlb.1009686","article-title":"The role of CD200 in immunity to B cell lymphoma","volume":"88","author":"Wong","year":"2010","journal-title":"J Leukoc Biol"},{"key":"key\n\t\t\t\t20180602034122_b11-1420837","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.coi.2012.01.002","article-title":"CD200R signaling in tumor tolerance and inflammation: a tricky balance","volume":"24","author":"Rygiel","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"key\n\t\t\t\t20180602034122_b12-1420837","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.leukres.2009.01.017","article-title":"CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia","volume":"33","author":"Palumbo","year":"2009","journal-title":"Leuk Res"},{"key":"key\n\t\t\t\t20180602034122_b13-1420837","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2141.2009.07644.x","article-title":"CD200\/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells","volume":"145","author":"Brunetti","year":"2009","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180602034122_b14-1420837","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2141.2010.08555.x","article-title":"CD200 expression in plasma cell myeloma","volume":"153","author":"Olteanu","year":"2011","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180602034122_b15-1420837","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1309\/AJCP59UORCYZEVQO","article-title":"Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma","volume":"137","author":"Alapat","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602034122_b16-1420837","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2310\/JIM.0b013e31823908f9","article-title":"CD200 expression in B-cell chronic lymphoproliferative disorders","volume":"60","author":"El Desoukey","year":"2012","journal-title":"J Investig Med"},{"key":"key\n\t\t\t\t20180602034122_b17-1420837","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1309\/AJCPEBK31VQQNDDR","article-title":"CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders","volume":"140","author":"Pillai","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602034122_b18-1420837","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/cytob.21128","article-title":"CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry","volume":"86","author":"Sandes","year":"2014","journal-title":"Cytometry B Clin Cytom"},{"key":"key\n\t\t\t\t20180602034122_b19-1420837","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1309\/AJCP38XRRUGSQOVC","article-title":"CD200 (OX-2 membrane glycoprotein) expression in B cell\u2013derived neoplasms","volume":"134","author":"Dorfman","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602034122_b20-1420837","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1182\/blood-2006-06-029355","article-title":"CD200 is a new prognostic factor in multiple myeloma","volume":"108","author":"Moreaux","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034122_b21-1420837","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/sj.leu.2404559","article-title":"CD200 as a prognostic factor in acute myeloid leukaemia","volume":"21","author":"Tonks","year":"2007","journal-title":"Leukemia"},{"issue":"suppl 1","key":"key\n\t\t\t\t20180602034122_b22-1420837","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1002\/cyto.b.20363","article-title":"2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia","volume":"72","author":"Wood","year":"2007","journal-title":"Cytometry B Clin Cytom"},{"key":"key\n\t\t\t\t20180602034122_b23-1420837","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-61779-074-4_18","article-title":"Cytogenetic analysis and reporting","volume":"730","author":"Campbell","year":"2011","journal-title":"Methods Mol Biol"},{"key":"key\n\t\t\t\t20180602034122_b24-1420837","volume-title":"An International System for Human Cytogenetic Nomenclature","author":"Shaffer","year":"2013"},{"key":"key\n\t\t\t\t20180602034122_b25-1420837","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.humpath.2012.07.005","article-title":"Chronic lymphocytic leukemia with t(14;18)(q32;q21)","volume":"44","author":"Tang","year":"2013","journal-title":"Hum Pathol"},{"key":"key\n\t\t\t\t20180602034122_b26-1420837","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1073\/pnas.0510081103","article-title":"Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation","volume":"103","author":"McWhirter","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180602034122_b27-1420837","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"van Dongen","year":"2012","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602034122_b28-1420837","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbrc.2007.11.103","article-title":"CD200: a putative therapeutic target in cancer","volume":"366","author":"Moreaux","year":"2008","journal-title":"Biochem Biophys Res Commun"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/142\/6\/837\/24999575\/ajcpath142-0837.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T03:43:04Z","timestamp":1566013384000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/142\/6\/837\/1767139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,12,1]]},"published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpbv9elxc0ecvl","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,12,1]]},"published":{"date-parts":[[2014,12,1]]}}}